학술논문
Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial
Document Type
Article
Author
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 1 August 2023, 29(15):2808-2815)
Subject
Language
English
ISSN
15573265
10780432
10780432